Cargando…
Hidradenitis suppurativa and adalimumab in the COVID-19 era
Autores principales: | Marzano, Angelo Valerio, Moltrasio, Chiara, Genovese, Giovanni, Muratori, Simona, Dapavo, Paolo, Fabbrocini, Gabriella, Patrizi, Annalisa, Sechi, Andrea, Micali, Giuseppe, Pellegrino, Michele, Gisondi, Paolo, Dini, Valentina, Bianchi, Luca, Fania, Luca, Offidani, Annamaria, Prignano, Francesca, Atzori, Laura, Miraglia, Emanuele, Cannavò, Serafinella Patrizia, Bettoli, Vincenzo, Stingeni, Luca, Balestri, Riccardo, Venturini, Marina, Peris, Ketty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Libbey Eurotext
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880651/ https://www.ncbi.nlm.nih.gov/pubmed/33337329 http://dx.doi.org/10.1684/ejd.2020.3927 |
Ejemplares similares
-
Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore
por: Marzano, A.V., et al.
Publicado: (2020) -
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study
por: Burlando, Martina, et al.
Publicado: (2022) -
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
por: Peris, K., et al.
Publicado: (2019) -
HIDRAdisk: an innovative visual tool to assess the burden of hidradenitis suppurativa
por: Chiricozzi, A., et al.
Publicado: (2018) -
Prevalence of Neuropathic Pain and Related Characteristics in Hidradenitis Suppurativa: A Cross-Sectional Study
por: Garcovich, Simone, et al.
Publicado: (2020)